NEWS

Our Latest News

ARCHIMED Pharma Services announces the spin-off of portfolio company Suanfarma’s subsidiary, SuanNutra

The corporate carve-out is part of Suanfarma’s strategy to aggressively build its core business in the active pharmaceutical ingredient market. SuanNutra, which accounts for approximately a quarter of Suanfarma’s sales, is a scalable, globally recognized leader in the nutraceutical ingredients sector.

ARCHIMED Pharma Services announces the spin-off of portfolio company Suanfarma’s subsidiary, SuanNutra

ARCHIMED completes seventh acquisition for NAMSA, the world leader in Medical Device testing services

March

27,

2023

Majority owner ARCHIMED and partners CAPZA and Siparex finance add-on acquisition by European safety testing company – and French market leader – CARSO

March

16,

2023

ARCHIMED buys WiQo, a pioneer in the field of aesthetic medicine

March

9,

2023

ARCHIMED invests in PlasmidFactory, a German gene and cell therapy specialist

October

7,

2022

ARCHIMED Impact Report 2021 – Investing for Better Healthcare: a Global Challenge

October

4,

2022

ARCHIMED acquires Nasdaq-listed Natus Medical Incorporated in $1.1 billion take-private deal

July

21,

2022

< 1 … 4 5 6 7 8 … 17 >

368